By proceeding, you agree to our Terms of Use and Privacy Policy.
Research Scientist
#assaydevelopment #targetengagement
#Northamerica
Ani Michaud is currently working as Research Scientist 4 at Promega Corporation.
Senior Scientist II
#assaydevelopment #cell
#NorthAmerica
Dr. Ben Clarke coordinates collaborative for USP’s physical reference standards, for monoclonal antibodies, cell, and gene therapy. Before joining USP, Ben developed potency bioassays at GSK Vaccines
Senior Research Scientist II
#assaydevelopment #discovery
Bonnie Tillotson is currently working as Senior Scientist at C4 Therapeutics.
Senior Scientist
#assaydevelopment #cellculture
#Europe
Catja Freiburghaus is currently working as Senior Scientist Project Lead at Hansa Biopharma.
Chief Technology Officer & Senior Vice President
#drugdiscovery #assaydevelopment
Experienced Senior Researcher with a demonstrated history of working in the biotechnology industry. Strong professional skilled in Antibodies Therapeutics, Protein Chemistry, Molecular Biology, Biotec
Principal Investigator
#antibodies #assaydevelopment
Christine is currently working as a Principal Investigator, Biology at Arcus Biosciences
Senior Vice President of Immunology and Oncology Research
#immunology #DrugDiscovery #AssayDevelopment
Cristiana Guiducci, Ph.D., has served as Senior Vice President, Immunology and Oncology Research of Nurix since January 2021 and served as the company’s Vice President, Immunology and Oncology Researc
Vice President, Protein Degrader Platform
#assaydevelopment #drugdiscovery
Danette Daniels, Ph.D., joined Foghorn Therapeutics in February 2022 as VP of the Protein Degrader Platform. She brings more than 20 years of cancer research experience in focused areas of epigenetics
Founder & CEO
#assaydevelopment #proteinchemistry
Proficient and entrepreneurial scientist with a proven success record in increasing portfolio value through the conceptualization, discovery, development, and implementation of fit-for-purpose, PD/bio
Program Leader (CMC), RNA Vaccines
#MolecularBiology #AssayDevelopment #Biochemistry
With over 18 years of experience in the development of novel pharmaceutical assets, I have a proven track record of effectively overseeing pipeline assets programs.In addition to these skills, I am a
GIRFT Workstream Delivery Manager
#clinicalresearch #assaydevelopment
Emma is a Transformation lead at East Suffolk and North Essex Foundation Trust and also GIRFT’s programme lead for ‘IP3D’-a programme aimed at Improving the Perioperative Pathway for People with Diabe
Chief Executive Officer & Founder
#assaydevelopment #biotechnology
Founder and CEO of Chameleon Biosciences. Expertise includes AAV and Lenti-virus based vector production and characterization, Immunology, drug development and regulatory guidelines.